The Ethics of Health Care Delivery in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania

J Empir Res Hum Res Ethics. 2018 Feb;13(1):26-41. doi: 10.1177/1556264617742236. Epub 2017 Nov 28.

Abstract

This study explores ethical issues raised in providing medical care to participants and communities of low-resource settings involved in a Phase II/III pediatric malaria vaccine trial (PMVT). We conducted 52 key informant interviews with major stakeholders of an international multi-center PMVT (GSK/PATH-MVI RTS,S) (NCT00866619) in Ghana and Tanzania. Based on their stakeholder experiences, the responses fell into three main themes: (a) undue inducement, (b) community disparities, and (c) broad therapeutic misconceptions. The study identified the critical ethical aspects, from the perspectives of stakeholders, of delivering health care during a PMVT. The study showed that integrating research into health care services needs to be addressed in a manner that upholds the favorable risk-benefit ratio of research and attends to the health needs of local populations. The implementation of research should aim to improve local standards of care through building a collaborative agenda with local institutions and systems of health.

Keywords: disparity; ethics; therapeutic misconception; undue inducement; vaccines.

Publication types

  • Clinical Trial, Phase II
  • Clinical Trial, Phase III
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Attitude
  • Biomedical Research / ethics*
  • Child, Preschool
  • Delivery of Health Care / ethics*
  • Developing Countries
  • Ethics, Clinical*
  • Ethics, Research
  • Ghana
  • Health Resources
  • Health Services / ethics*
  • Humans
  • Infant
  • Malaria / prevention & control*
  • Malaria Vaccines*
  • Motivation
  • Pediatrics / ethics
  • Poverty
  • Research Design
  • Residence Characteristics
  • Stakeholder Participation
  • Tanzania
  • Therapeutic Misconception*

Substances

  • Malaria Vaccines

Associated data

  • ClinicalTrials.gov/NCT00866619